These “mini-organs” are grown from five common bat species found across Asia and Europe and represent four different organs—airway, lungs, kidneys, and small intestine.
read more
Researchers in Pittsburg have developed and tested an infectious diseases platform that can prevent the spread of hospital-based infections—and thereby deaths—while saving hundreds of thousands of dollars.
read more
Researchers found that the vaccine not only targeted the COVID-19 virus, it also unexpectedly helped to reduce and control innate inflammation to other bacterial and fungal pathogens not related to the vaccine target.
read more
Pregnancy may offer some protection from developing Long COVID, found a new study led by Weill Cornell Medicine.
read more
An advanced type of MRI uncovers significant lung abnormalities in children and adolescents with long COVID.
read more
The nanoparticle-based vaccine shows promise against many variants of SARS-CoV-2, as well as related sarbecoviruses that could jump to humans.
read more
Researchers warn the animals we eat could be the gateway for a pandemic in the form of antimicrobial resistance, unleashing a wave of deadly superbugs.
read more
Building upon groundbreaking research demonstrating how the SARS-CoV-2 virus disrupts mitochondrial function in multiple organs, researchers from Children’s Hospital of Philadelphia (CHOP) demonstrated that mitochondrially-targeted antioxidants could reduce the effects of the virus while avoiding viral gene mutation resistance, a strategy that may be useful for treating other viruses.
read more
Researchers at the University of California San Diego have found that a molecule previously identified in cancer research plays a critical role in the immune response to COVID-19. The molecule, PI3K gamma, facilitates the entry of inflammatory myeloid cells into lung tissue infected with SARS-CoV-2, the virus causing COVID-19. This infiltration often leads to severe organ damage.
read more
Researchers have developed new technology called “proactive vaccinology” that can protect against a broad range of coronaviruses – including ones that have not been identified yet. In mice, the new vaccine raised a broad immune response, even for those who were pre-immunized with SARS-CoV-2. With a simple design and broad applicability, the team hopes to bring their new technology to vaccine development for many health challenges.
read more
Researchers developed a technique—Targeted Accurate RNA Consensus sequencing (tARC-seq)—that measures mutations that occur during RNA replication of the SARS-CoV-2 virus.
read more
Research finds that differences in how the nasal cells of young and elderly people respond to the SARS-CoV-2 virus may explain why children experience milder COVID-19 symptoms.
read more
A new study mexamines patterns of inflammation detectable in the blood of people with long COVID. The findings can inform new targeted immune therapies for the treatment of long COVID.
read more
Researchers developed and applied methodological tools to analyze nearly 12 million viral genomes present on public databases.
read more
Researchers discovered a possible way to predict which patients with severe COVID-19 are likely to recover and which are likely to suffer long-haul lung problems.
read more